School of Medicine

Raj Dhar, MD, at the School of Medicine, co-led a study that showed that the long-standing practice of treating deceased organ donors with thyroid hormone does not help preserve heart function, may cause harm and should be discontinued.

Jennie H. Kwon, DO, an associate professor of medicine and chief of the section of Healthcare Epidemiology & Antimicrobial Stewardship at the School of Medicine, has been awarded a $3.6 million grant from the Centers for Disease Control and Prevention to lead a multisite clinical study.

In diseased hearts, low-dose radiation therapy appears to improve heart function. The new research, from the School of Medicine, could lead to new heart failure therapies.

Researchers at Washington University School of Medicine in St. Louis have found an innovative way to block infection by a variety of alphaviruses, a group of mosquito-borne viruses that can cause joint and brain infections in people.

Researchers at the School of Medicine have found that a form of cholesterol known as cholesteryl esters builds up in the brains of mice with Alzheimer’s-like disease, and that clearing out the cholesteryl esters helps prevent brain damage and behavioral changes.

A collaboration led by the School of Medicine aims to advance long-COVID care in medically vulnerable and underserved communities in the St. Louis metropolitan region and in rural Missouri. The WashU team won a five-year federal grant totaling $4.5 million.

The Program in Audiology and Communication Sciences at the School of Medicine has been awarded two grants from the U.S. Department of Education that combined will provide over $2.3 million in support of its graduate training programs.

Kathleen K. Dixon, a retired emeritus instructor in the Program in Physical Therapy at the School of Medicine, died Nov. 5 at a retirement center in Richmond Heights, Mo., following a long illness. She was 90.

A device aimed at enabling physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration “Breakthrough Device” designation. The device includes Washington University technology.

Janice Robertson, of the School of Medicine, received a two-year $155,500 grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH).